ANIP News and Press, ANI Pharmaceuticals Inc. From 04/27/23

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its first quarter 2023 financial results on Monday, May 8, 2023, prior to the market open. Nikhil Lalwani, President and Chief Executive Officer, and Ste...

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright BioConnect Investor Conference at the NASDAQ Headquarters in New York City as follows: Th...

2023-04-24 07:30:10 ET ANI Pharmaceuticals ( NASDAQ: ANIP ) said the U.S. Food and Drug Administration (FDA) approved its generic antibacterial medicine Nitrofurantoin Oral Suspension USP 25 mg/5 ml. The drug is the generic version of Furadantin, an antibiotic used to treat ur...

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Nitrofurantoin Oral Suspension USP, 25 mg/5 ml. ANI’s Nitrofurantoin Oral Suspension is th...

2023-04-04 07:29:16 ET The U.S. Food and Drug Administration (FDA) approved ANI Pharmaceuticals' ( NASDAQ: ANIP ) generic cholesterol-lowering drug, Colestipol Hydrochloride Tablets USP 1 g. The company said its Colestipol Hydrochloride tablets are the generic version of the r...

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Colestipol Hydrochloride Tablets USP, 1 g. ANI’s Colestipol Hydrochloride Tablets are the ...

2023-03-10 17:31:23 ET Amid concerns about smaller pharma and biotech companies' exposure to Silicon Valley Bank ( SIVB ), a number of them have disclosed that they have no relationship with the FDIC-shuttered financial institution . Among the larger ones are Cara Therapeu...

2023-03-09 13:10:20 ET ANI Pharmaceuticals, Inc. (ANIP) Q4 2022 Earnings Conference Call March 09, 2023, 08:30 ET Company Participants Judy DiClemente - IR Nikhil Lalwani - President, CEO & Director Stephen Carey - CFO, SVP, Finance & Corporate Secretary ...

2023-03-09 06:52:38 ET ANI Pharmaceuticals press release ( NASDAQ: ANIP ): Q4 Non-GAAP EPS of $0.76 beats by $0.09 . Revenue of $94.2M (+54.7% Y/Y) beats by $8.06M . Cash and cash equivalents were $48.2 million, net accounts receivable was $165.4 million, and f...

Fourth Quarter and Full Year 2022 Financial Results -- Q4 net revenues of $94.2 million, net loss available to common shareholders of $(4.7) million and diluted GAAP loss per share of $(0.28) – -- Q4 Adjusted non-GAAP EBITDA of $23.3 million and adjusted non-GAAP diluted ...